Back to Research Library
Compound Profiles 7 min read

GHK-Cu & Gene Expression: The Epigenetic Reset

How GHK-Cu interacts with human DNA, resets ~4,000 genes, and what this means for anti-ageing research.

What is GHK-Cu?

GHK-Cu is a copper-bound tripeptide first characterised in human blood plasma in 1973. It has since become one of the most studied compounds in skin biology and tissue regeneration research for its capacity to influence cellular behaviour at a genomic level.

Plasma concentrations of GHK-Cu are highest during youth and fall by more than 60 percent over a lifetime — a decline that correlates temporally with the deterioration of tissue quality and the emergence of ageing-associated biological changes.

The Research

A wide-ranging genomic analysis used the Broad Institute's Connectivity Map database to examine how GHK-Cu influences global gene expression patterns. The analysis evaluated the peptide's impact across the full human genome to determine the extent of its regulatory effects.

Reference DOI: 10.3390/ijms19071987

Key Research Findings

  • •Modulates expression of approximately 4,000 human genes — representing close to 30% of the entire genome
  • •Stimulates collagen and elastin production by as much as 70%
  • •Promotes growth of new blood vessels and supports nerve fibre extension
  • •Suppresses gene networks associated with cellular degradation and chronic inflammation

The data suggest that GHK-Cu influences cells in ways that partially reverse age-associated expression patterns.

What This Means

The conventional approach to anti-ageing has largely focused on surface-level interventions. GHK-Cu research positions epigenetic regulation as a potential alternative strategy — one that targets gene expression rather than simply addressing visible outcomes.

Changes in expression are cumulative and require sustained compound exposure, but the scope of genomic influence documented in the research represents a meaningful area of scientific interest.

Detailed Research Findings

Collagen and Skin Architecture

Multiple published studies document GHK-Cu's effects on:

  • •Upregulation of collagen synthesis (including types I, III, IV, V, and VII)
  • •Increased production of elastin and glycosaminoglycans
  • •Activation of dermal fibroblast populations
  • •Measurable reductions in fine line depth and improvements in skin density in controlled evaluations

DNA Integrity and Repair

At the genomic level, research shows:

  • •Enhanced expression of DNA repair gene networks
  • •Lower levels of oxidative DNA damage markers in treated subjects
  • •Modulation of p53-regulated apoptosis pathways in healthy cell populations

Vascular and Nerve Repair

  • •Recruits macrophages and mast cells to areas of tissue damage
  • •Upregulates VEGF (vascular endothelial growth factor) signalling
  • •Encourages neurotrophic activity and nerve fibre outgrowth
  • •Accelerates wound closure across multiple animal model systems

Inflammatory Gene Regulation

GHK-Cu reduces activity in multiple pro-inflammatory gene networks, including those encoding:

  • •TNF-alpha
  • •IL-6
  • •Components of the NF-kB signalling pathway

Physical Properties

  • •Structure: Glycyl-L-histidyl-L-lysine complexed with Cu²⁺
  • •Molecular Weight: ~340 Da (tripeptide component) + copper ion
  • •Biological source: Human blood plasma, saliva, and urine
  • •Appearance: Blue lyophilised powder (characteristic of copper coordination)
  • •Solubility: Freely water soluble

Storage Recommendations

Store lyophilised GHK-Cu at -20°C, protected from light and moisture. Following reconstitution with bacteriostatic water, refrigerate at 2–8°C and use within 28 days. Do not subject to repeated freeze-thaw cycles.


This article is for research and educational purposes only. GHK-Cu is not approved as a therapeutic drug.

Research Use Only: All products are sold strictly for in-vitro laboratory research purposes. Not for human or veterinary consumption. Not approved by the MHRA for any therapeutic use. Not intended to diagnose, treat, cure, or prevent any disease. Purchaser must be 18+ and a qualified researcher.

King Pharma

King Pharma is a UK-based supplier of independently verified, laboratory-grade peptide research compounds. All products are supplied for qualified scientific research use only.

⚠️ None of our products are intended for human use. No medicinal claims are made or implied.

© 2026 King Pharma Ltd. All rights reserved. Registered in England & Wales.

Secure payments:
VISAMCAMEXMaestro